Tylenol Recall in Effect Includes Several Other Drugs

Motrin, Benadryl and Rolaids are also part of recall by Johnson & Johnson subsidiary
By Andrea Mongler
HealthDay Reporter

WEDNESDAY, Jan. 20 (HealthDay News) -- McNeil Consumer Healthcare has recently expanded its voluntary recall of some over-the-counter drugs to include about 500 lots of products, according to officials from the Office of Compliance in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration.

McNeil, a Johnson & Johnson subsidiary, started its recall in September, and at the time it was limited to certain lots of Tylenol. The company expanded the recall in December and again last week, and it now includes certain lots of Motrin, Benadryl, Rolaids and St. Joseph aspirin.

The recall is a response to an uncharacteristic moldy, musty or mildew-like odor reported by consumers. In a small number of cases, the odor was associated with gastrointestinal events, including nausea, stomach pain, vomiting and diarrhea. McNeil has determined that the odor is caused by trace amounts of the chemical 2,4,6-tribromoanisole, which is used to treat the wooden pallets on which the drugs' packaging material is transported and stored.

"The health effects of this chemical have not been well-studied, but no serious events have been documented in the medical literature," said Deborah M. Autor, director of the Office of Compliance in the Center for Drug Evaluation and Research at the FDA, during a Jan. 15 news conference.

More Information

Copyright © 2010 ScoutNews, LLC. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

Dogs as Pets, Visitors, Therapists and Assistants
Home Healthcare Nurse, November/December 2014
Free access will expire on January 5, 2015.


Tracheostomy Care
Nursing2014 Critical Care, November 2014
Free access will expire on December 22, 2014.


Effective management of ARDS
The Nurse Practitioner, 13December 2014
Free access will expire on December 22, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events